In a bid to extend radiation oncology applications, engineers at Philips Healthcare have widened the bore of the company’s premium Gemini TF PET/CT scanner to create the industry’s first big-bore hybrid. Priced north of $2 million, the Gemini TF Big Bore is scheduled to begin shipping next year. Philips is showcasing the Big Bore this week on the RSNA exhibit floor, and beta testing will begin at the University of Pennsylvania Hospital in the next several months.
In a bid to extend radiation oncology applications, engineers at Philips Healthcare have widened the bore of the company's premium Gemini TF PET/CT scanner to create the industry's first big-bore hybrid. Priced north of $2 million, the Gemini TF Big Bore is scheduled to begin shipping next year. Philips is showcasing the Big Bore this week on the RSNA exhibit floor, and beta testing will begin at the University of Pennsylvania Hospital in the next several months.
Philips' proprietary TruFlight time-of-flight technology, which characterizes the Gemini TF, allowed the company to widen the bore from 71.7 cm to 85 cm without compromising image quality or scan time, according to the company. The new system offers a combination of accessories and localization devices designed specifically for use in radiation oncology. Its large bore meets treatment planning requirements for patients who must be scanned in extended positions, as in cases of breast and colorectal scanning, by allowing them to be positioned for simulation in the same manner as they would be positioned to receive therapy.
Precise measurements are particularly important in radiation treatment planning. Toward that end, the company has integrated a more rigid table than the one used on the conventional Gemini PET/CT, providing very precise localization based on rigid patient framing.
Photon-Counting Computed Tomography: Eleven Takeaways from a New Literature Review
May 27th 2025In a review of 155 studies, researchers examined the capabilities of photon-counting computed tomography (PCCT) for enhanced accuracy, tissue characterization, artifact reduction and reduced radiation dosing across thoracic, abdominal, and cardiothoracic imaging applications.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
Can Emerging AI Software Offer Detection of CAD on CCTA on Par with Radiologists?
May 14th 2025In a study involving over 1,000 patients who had coronary computed tomography angiography (CCTA) exams, AI software demonstrated a 90 percent AUC for assessments of cases > CAD-RADS 3 and 4A and had a 98 percent NPV for obstructive coronary artery disease.